@prefix : <http://www.s-cubed.dk/ZDUMMYMED/V1#> .
@prefix pr: <http://www.assero.co.uk/Protocol#> .
@prefix isoC: <http://www.assero.co.uk/ISO11179Concepts#> .
@prefix isoT: <http://www.assero.co.uk/ISO11179Types#> .
@prefix isoR: <http://www.assero.co.uk/ISO11179Registration#> .
@prefix isoI: <http://www.assero.co.uk/ISO11179Identification#> .
@prefix bo: <http://www.assero.co.uk/BusinessOperational#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

<http://www.s-cubed.dk/ZDUMMYMED/V1>
	rdf:type owl:Ontology ;
.
<http://www.assero.co.uk/EP#4dedffda-dd37-4d8f-bbdc-a71b57eb3f78>
	rdf:type pr:Epoch ;
	isoC:label "Screening"^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#d94f769d-f685-465e-91ee-a6117a2846f6>
	rdf:type pr:Epoch ;
	isoC:label "Double Blind Treatment"^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/EP#e4fd7dce-a459-426c-babc-c4c414d8b160>
	rdf:type pr:Epoch ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:ordinal "3"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#4f8f6f01-465b-4548-911f-db764305947c>
	rdf:type pr:Arm ;
	isoC:label "ZD CP"^^xsd:string ;
	pr:description "Regimen ZD, CP"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "1"^^xsd:integer ;
.
<http://www.assero.co.uk/ARM#9a137c6c-10c3-4955-9e0a-c5b885af7b0f>
	rdf:type pr:Arm ;
	isoC:label "CP ZD"^^xsd:string ;
	pr:description "Regimen CP, ZD"^^xsd:string ;
	pr:armType ""^^xsd:string ;
	pr:ordinal "2"^^xsd:integer ;
.
<http://www.assero.co.uk/ELE#502870d0-e563-47e4-8958-9d912c982274>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#4f8f6f01-465b-4548-911f-db764305947c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#4dedffda-dd37-4d8f-bbdc-a71b57eb3f78> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
.
<http://www.assero.co.uk/ELE#0dff417d-9394-4217-9df3-bbf8e0711a9b>
	rdf:type pr:Element ;
	isoC:label "Screening"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#9a137c6c-10c3-4955-9e0a-c5b885af7b0f> ;
	pr:inEpoch <http://www.assero.co.uk/EP#4dedffda-dd37-4d8f-bbdc-a71b57eb3f78> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
.
<http://www.assero.co.uk/ELE#76b2ccf7-8488-4708-a506-14c71d40358c>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#4f8f6f01-465b-4548-911f-db764305947c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#d94f769d-f685-465e-91ee-a6117a2846f6> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#fa538caa-76fe-47cd-b0e7-360974814bbe> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#3083e455-df04-49a8-bd49-29765c04ee02> ;
.
<http://www.assero.co.uk/ELE#8a773ca3-19a8-4662-92d1-3507b5759702>
	rdf:type pr:Element ;
	isoC:label "DB Treatment"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#9a137c6c-10c3-4955-9e0a-c5b885af7b0f> ;
	pr:inEpoch <http://www.assero.co.uk/EP#d94f769d-f685-465e-91ee-a6117a2846f6> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#fa538caa-76fe-47cd-b0e7-360974814bbe> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#3083e455-df04-49a8-bd49-29765c04ee02> ;
.
<http://www.assero.co.uk/ELE#935a1b8d-d817-4860-ba23-2ba7bcac2a5b>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#4f8f6f01-465b-4548-911f-db764305947c> ;
	pr:inEpoch <http://www.assero.co.uk/EP#e4fd7dce-a459-426c-babc-c4c414d8b160> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#6cb201dd-7997-44dd-a8fd-9f985792279b> ;
.
<http://www.assero.co.uk/ELE#ed95318b-5862-47c1-a83d-6046935adc11>
	rdf:type pr:Element ;
	isoC:label "Follow Up"^^xsd:string ;
	pr:inArm <http://www.assero.co.uk/ARM#9a137c6c-10c3-4955-9e0a-c5b885af7b0f> ;
	pr:inEpoch <http://www.assero.co.uk/EP#e4fd7dce-a459-426c-babc-c4c414d8b160> ;
	pr:containsTimepoint <http://www.assero.co.uk/TP#6cb201dd-7997-44dd-a8fd-9f985792279b> ;
.
:PR
	rdf:type pr:Protocol ;
	isoC:label "ZDUMMYMED"^^xsd:string ;
	isoT:hasState :PR_RS ;
	isoT:hasIdentifier :PR_SI ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T10:44:17+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:acronym "ZDUMMYMED"^^xsd:string ;
	pr:title "A 26 weeks, randomized, double-blind, comparator-controlled, cross-over group, Efficacy and Safety trial of once daily ZD 5mg oral, as add-on to Basal Insulin in Elderly (>60 years old) Type 2 Diabetes Mellitus patients with insufficient glycemic control."^^xsd:string ;
	pr:shortTitle "ZDUMMYMED"^^xsd:string ;
	pr:studyPhase :PR_TUC3 ;
	pr:studyType :PR_TUC4 ;
	pr:interventionModel :PR_TUC1 ;
	pr:masking :PR_TUC2 ;
	pr:forIndication <http://www.s-cubed.dk/IND_TYPE_2_DIABETES_MELLITUS/V1#IND> ;
	pr:inTa <http://www.s-cubed.dk/TA_M/V1#TA> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#4f8f6f01-465b-4548-911f-db764305947c> ;
	pr:specifiesArm <http://www.assero.co.uk/ARM#9a137c6c-10c3-4955-9e0a-c5b885af7b0f> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#4dedffda-dd37-4d8f-bbdc-a71b57eb3f78> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#d94f769d-f685-465e-91ee-a6117a2846f6> ;
	pr:specifiesEpoch <http://www.assero.co.uk/EP#e4fd7dce-a459-426c-babc-c4c414d8b160> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#6009af49-ddcf-42c3-8bd6-6ccbcaac35c8> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#9a87d899-9675-4971-b524-839bca952113> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#7992a2b5-22ff-4e77-b1dd-8e97f859192c> ;
	pr:specifiesObjective <http://www.assero.co.uk/PROBJ#f41c55d0-230b-4338-9ab3-10b84bafd761> ;
.
:PR_RS
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
:PR_SI
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZDUMMYMED"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
:PR_TUC3
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "3"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66737/V42#C66737_C15602> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC4
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "4"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99077/V28#C99077_C98388> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC1
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "1"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C99076/V28#C99076_C82637> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
:PR_TUC2
	rdf:type bo:TucReference ;
	isoC:label ""^^xsd:string ;
	bo:enabled "true"^^xsd:boolean ;
	bo:optional "false"^^xsd:boolean ;
	bo:ordinal "2"^^xsd:positiveInteger ;
	bo:reference <http://www.cdisc.org/C66735/V4#C66735_C15228> ;
	bo:context <http://www.cdisc.org/CT/V68#TH> ;
	bo:localLabel ""^^xsd:string ;
.
<http://www.s-cubed.dk/ZDUMMYMED_STUDY/V1#ST>
	rdf:type pr:Study ;
	isoC:label "Study for the ZDUMMYMED protocol"^^xsd:string ;
	isoT:hasState <http://www.s-cubed.dk/ZDUMMYMED_STUDY/V1#ST_RS> ;
	isoT:hasIdentifier <http://www.s-cubed.dk/ZDUMMYMED_STUDY/V1#ST_SI> ;
	isoT:origin ""^^xsd:string ;
	isoT:changeDescription ""^^xsd:string ;
	isoT:creationDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoT:lastChangeDate "2021-03-13T10:44:17+01:00"^^xsd:dateTime ;
	isoT:explanatoryComment ""^^xsd:string ;
	pr:description "Not set yet."^^xsd:string ;
	pr:implements :PR ;
.
<http://www.s-cubed.dk/ZDUMMYMED_STUDY/V1#ST_RS>
	rdf:type isoR:RegistrationState ;
	isoR:registrationStatus "Incomplete"^^xsd:string ;
	isoR:administrativeNote ""^^xsd:string ;
	isoR:effectiveDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:untilDate "2016-01-01T00:00:00+00:00"^^xsd:dateTime ;
	isoR:unresolvedIssue ""^^xsd:string ;
	isoR:administrativeStatus ""^^xsd:string ;
	isoR:previousState "Incomplete"^^xsd:string ;
	isoR:multipleEdit "false"^^xsd:boolean ;
	isoR:byAuthority <http://www.assero.co.uk/RA#DUNS123456789> ;
.
<http://www.s-cubed.dk/ZDUMMYMED_STUDY/V1#ST_SI>
	rdf:type isoI:ScopedIdentifier ;
	isoI:identifier "ZDUMMYMED STUDY"^^xsd:string ;
	isoI:versionLabel ""^^xsd:string ;
	isoI:version "1"^^xsd:positiveInteger ;
	isoI:semanticVersion "0.1.0"^^xsd:string ;
	isoI:hasScope <http://www.assero.co.uk/NS#SCUBED> ;
.
<http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724>
	rdf:type pr:Visit ;
	isoC:label "Baseline"^^xsd:string ;
	pr:shortName "Vis#01"^^xsd:string ;
.
<http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630>
	rdf:type pr:Visit ;
	isoC:label "Week 1"^^xsd:string ;
	pr:shortName "Vis#02"^^xsd:string ;
.
<http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13>
	rdf:type pr:Visit ;
	isoC:label "Week 6"^^xsd:string ;
	pr:shortName "Vis#03"^^xsd:string ;
.
<http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95>
	rdf:type pr:Visit ;
	isoC:label "Week 12"^^xsd:string ;
	pr:shortName "Vis#04"^^xsd:string ;
.
<http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb>
	rdf:type pr:Visit ;
	isoC:label "Week 18"^^xsd:string ;
	pr:shortName "Vis#05"^^xsd:string ;
.
<http://www.assero.co.uk/VI#50347305a9cc2e647f8a8e7487c9a46cefa1e690>
	rdf:type pr:Visit ;
	isoC:label "Week 24"^^xsd:string ;
	pr:shortName "Vis#06"^^xsd:string ;
.
<http://www.assero.co.uk/VI#897ded48a15c04d82654d57ae11bac9e9445f877>
	rdf:type pr:Visit ;
	isoC:label "End of Study"^^xsd:string ;
	pr:shortName "Vis#07"^^xsd:string ;
.
<http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8>
	rdf:type pr:Timepoint ;
	isoC:label "TP1"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_a9c5888f-51e8-4b43-974a-7307e95b518c> ;
	pr:inVisit <http://www.assero.co.uk/VI#43a4674c8dbb9a7a54fca337c8685f379ae67724> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#f3b9194a-a30c-464b-b340-301f20a17f34> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#ea6a66be-70f2-4771-a859-c15131546d9d> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#2e6a9719-ebfe-4d15-a79f-6be843bf4459> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#e1667f1a-69fc-4e39-9bcb-e1c28cfcd81c> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#dd82ca29-aa9f-4f55-b3be-4e7f87b460ef> ;
.
<http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800>
	rdf:type pr:Timepoint ;
	isoC:label "TP2"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_86cd9d65-324a-436c-9b29-885753f57125> ;
	pr:inVisit <http://www.assero.co.uk/VI#26b1c771fb3760f35a954cc6f948de851dfae630> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#e9e46dd3-c78d-4676-812f-3f5eca7095f0> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#2c1e6576-58e4-4ce1-9c9a-9d55bc3ba508> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#14d3b4be-050d-47f7-af09-c026d6615551> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#b273f957-328b-4472-aeec-f3709563ad02> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#096864ae-2014-43a3-a8db-0656a4c859f4> ;
.
<http://www.assero.co.uk/TP#fa538caa-76fe-47cd-b0e7-360974814bbe>
	rdf:type pr:Timepoint ;
	isoC:label "TP3"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_a2bb708e-dba0-4731-bb2c-e5f9cd0054f1> ;
	pr:inVisit <http://www.assero.co.uk/VI#24dc77d16170cb26034f547e8b7ac56f1a0f2a13> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#103713bb-1e29-4373-94a8-7c2a41fa1683> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#1c27b346-6104-4c5c-9f4f-4059672d97ad> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#e7e45411-132c-48e4-9b3b-16016f956402> ;
.
<http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494>
	rdf:type pr:Timepoint ;
	isoC:label "TP4"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_e8358f63-3ff6-4ecd-9c5a-b95ceff8b078> ;
	pr:inVisit <http://www.assero.co.uk/VI#3ea4f410ece4b621097a543af2a7097e53ef1f95> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#c1ec56cf-769b-44a6-8327-d6d1c75c64dd> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#4396f2a9-f569-4890-9094-c6d6658870b7> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#af716b8b-fe7a-4a4d-8bf2-b3874d22ff06> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#55f565be-c6a4-4f0f-abbb-de8e0f90dc86> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#29479fdb-cb07-4cb3-9a37-8c1d30026a65> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#44d393a2-6431-4704-8417-7dca96f63cd8> ;
.
<http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c>
	rdf:type pr:Timepoint ;
	isoC:label "TP5"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_ae6a920f-fceb-4717-a9af-6cfd3c6540a9> ;
	pr:inVisit <http://www.assero.co.uk/VI#d75c7fe12a17dd078cf0c882a4005b67d538b0bb> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#fe6a9808-65d2-4291-b50c-1cd9eba877c6> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#9f48290d-086b-408a-a558-4f72e0749718> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#703e022e-e531-4033-8f7b-06edf484e919> ;
.
<http://www.assero.co.uk/TP#3083e455-df04-49a8-bd49-29765c04ee02>
	rdf:type pr:Timepoint ;
	isoC:label "TP6"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_a8d25d85-7e8a-4ce5-8a6c-fb4bd346510f> ;
	pr:inVisit <http://www.assero.co.uk/VI#50347305a9cc2e647f8a8e7487c9a46cefa1e690> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#158dcbdf-6cdd-492c-967e-6f8464436df0> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#0e66b3b1-6e38-443a-a255-7507cc26eb12> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#75478e4b-656b-471a-be40-cd5835363105> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#8b18424f-57b8-4832-a041-1e60871087e3> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#e4ba66a6-2480-4e13-92f1-91961b0d4e09> ;
.
<http://www.assero.co.uk/TP#6cb201dd-7997-44dd-a8fd-9f985792279b>
	rdf:type pr:Timepoint ;
	isoC:label "TP7"^^xsd:string ;
	pr:atOffset <http://www.assero.co.uk/IC#TPO_85038e46-634b-47b2-b80c-f8a7ad57e063> ;
	pr:inVisit <http://www.assero.co.uk/VI#897ded48a15c04d82654d57ae11bac9e9445f877> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#b57ca734-7709-4b2e-9fe5-f33429716d5b> ;
	pr:hasPlanned <http://www.assero.co.uk/STBC#7b93c26e-3af5-4897-9d7d-04fde3ec8a05> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#aaa446c8-5187-4f3d-b2ba-26cc5f302b77> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#5126e0a1-b2e0-493c-a1d2-07e9525bbe7e> ;
	pr:hasPlanned <http://www.assero.co.uk/STFRM#3a5d56a5-e476-44d9-80a9-0d717c00a57c> ;
.
<http://www.assero.co.uk/IC#TPO_a9c5888f-51e8-4b43-974a-7307e95b518c>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "0"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_86cd9d65-324a-436c-9b29-885753f57125>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "604800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_a2bb708e-dba0-4731-bb2c-e5f9cd0054f1>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "3628800"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_e8358f63-3ff6-4ecd-9c5a-b95ceff8b078>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "7257600"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_ae6a920f-fceb-4717-a9af-6cfd3c6540a9>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "10886400"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_a8d25d85-7e8a-4ce5-8a6c-fb4bd346510f>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "14515200"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/IC#TPO_85038e46-634b-47b2-b80c-f8a7ad57e063>
	rdf:type pr:TimepointOffset ;
	isoC:label ""^^xsd:string ;
	pr:windowOffset "15120000"^^xsd:integer ;
	pr:windowMinus "0"^^xsd:integer ;
	pr:windowPlus "0"^^xsd:integer ;
	pr:unit "Week"^^xsd:string ;
.
<http://www.assero.co.uk/PROBJ#6009af49-ddcf-42c3-8bd6-6ccbcaac35c8>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ1"^^xsd:string ;
	pr:fullText "To assess the effect of Xanomeline Transdermal Therapeutic System (TTS) on the ADAS-Cog and CIBIC+ scores at Week 24 in participants with Mild to Moderate Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_1/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#9102647f-c04b-478d-8e4d-ae376973367a> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#b3132df9-46a4-40c4-9337-26d41c797fc7> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#9a87d899-9675-4971-b524-839bca952113>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ2"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_3/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#505a6b83-f1f8-4014-b271-d2d8198e891c> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#a9a96ec019494d5b8b041c1d2468061ae66e35d5> ;
.
<http://www.assero.co.uk/PROBJ#7992a2b5-22ff-4e77-b1dd-8e97f859192c>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ3"^^xsd:string ;
	pr:fullText "To document the safety profile of the xanomeline TTS."^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_4/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#3ed06e19-f297-48ee-85c9-049b627ebd03> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#8b550821-a916-4309-9075-846c8eb56661> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#ed529600-8460-4a88-8a99-0e6867d7a79d> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#8d352126-ac16-4ba0-bbb6-9226527a35e9> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#f41c55d0-230b-4338-9ab3-10b84bafd761>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ4"^^xsd:string ;
	pr:fullText "To assess the effect of xanomeline TTS on the measure of behavioral/neuropsychiatric symptoms in participants with  Alzheimer’s Disease"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_5/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#77a06553-f05b-4b3e-b5d2-b8b9ec9d871a> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PROBJ#b7fd2900-dc7a-474b-8216-6b98b61aa66d>
	rdf:type pr:ProtocolObjective ;
	isoC:label "LY246708 OBJ5"^^xsd:string ;
	pr:fullText "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas"^^xsd:string ;
	pr:derivedFromObjective <http://www.s-cubed.dk/OBJ_6/V1#OB> ;
	pr:isAssessedBy <http://www.assero.co.uk/PREND#8bfca9a9-aa83-43fa-bd41-c3bfbbe9dc78> ;
	pr:objectiveType <http://www.assero.co.uk/ENUM#b710a1f98200b22b534bf1269c5fa2c84e1b6d82> ;
.
<http://www.assero.co.uk/PREND#9102647f-c04b-478d-8e4d-ae376973367a>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP1"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Alzheimer’s Disease Assessment Scale – Cognitive Assessment (ADAS-Cog) 14 total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_1/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
.
<http://www.assero.co.uk/PREND#b3132df9-46a4-40c4-9337-26d41c797fc7>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP2"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8, 16 and 24 in the Clinician’s Interview-Based Impression of Change plus caregiver input (CIBIC+)"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_2/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
.
<http://www.assero.co.uk/PREND#505a6b83-f1f8-4014-b271-d2d8198e891c>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP3"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
.
<http://www.assero.co.uk/PREND#3ed06e19-f297-48ee-85c9-049b627ebd03>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP4"^^xsd:string ;
	pr:fullText "The proportion of participants with adverse events, serious adverse events (SAEs), and adverse events leading to study intervention discontinuation over the 24-week study intervention period"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_5/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
.
<http://www.assero.co.uk/PREND#8b550821-a916-4309-9075-846c8eb56661>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP5"^^xsd:string ;
	pr:fullText "The change from baseline to Week 12 in continuous laboratory tests: Hepatic Function Panel"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_6/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#fa538caa-76fe-47cd-b0e7-360974814bbe> ;
.
<http://www.assero.co.uk/PREND#ed529600-8460-4a88-8a99-0e6867d7a79d>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP6"^^xsd:string ;
	pr:fullText "The proportion of participants with abnormal (high or low) laboratory measures (urinalysis) during the postrandomization phase"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_7/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#fa538caa-76fe-47cd-b0e7-360974814bbe> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#8e063158-97be-44aa-b329-0d61a39df494> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#533d87eb-9e8d-4ef8-b064-53889f27c07c> ;
.
<http://www.assero.co.uk/PREND#8d352126-ac16-4ba0-bbb6-9226527a35e9>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP7"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in ECG parameter: QTcF"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_8/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
.
<http://www.assero.co.uk/PREND#77a06553-f05b-4b3e-b5d2-b8b9ec9d871a>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP8"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the Neuropsychiatric Inventory (NPI) total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
.
<http://www.assero.co.uk/PREND#8bfca9a9-aa83-43fa-bd41-c3bfbbe9dc78>
	rdf:type pr:ProtocolEndpoint ;
	isoC:label "LY246708 EP9"^^xsd:string ;
	pr:fullText "The change from baseline to Week 8 in the DAD total score"^^xsd:string ;
	pr:derivedFromEndpoint <http://www.s-cubed.dk/EP_9/V1#END> ;
	pr:primaryTimepoint <http://www.assero.co.uk/TP#e882a286-5143-4991-bed0-77b9b14778a8> ;
	pr:secondaryTimepoint <http://www.assero.co.uk/TP#bd440a70-7e43-414f-b479-2678e564b800> ;
.
<http://www.assero.co.uk/STFRM#f3b9194a-a30c-464b-b340-301f20a17f34>
	rdf:type pr:StudyForm ;
	isoC:label "Informed Consent"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/INFORMED_CONSENT_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#ea6a66be-70f2-4771-a859-c15131546d9d>
	rdf:type pr:StudyForm ;
	isoC:label "Demographics"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/DM_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#2e6a9719-ebfe-4d15-a79f-6be843bf4459>
	rdf:type pr:StudyForm ;
	isoC:label "Vital Signs"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/VITAL_SIGNS/V1#F> ;
.
<http://www.assero.co.uk/STBC#e1667f1a-69fc-4e39-9bcb-e1c28cfcd81c>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#dd82ca29-aa9f-4f55-b3be-4e7f87b460ef>
	rdf:type pr:StudyForm ;
	isoC:label "Routine Laboratory"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/LB_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#e9e46dd3-c78d-4676-812f-3f5eca7095f0>
	rdf:type pr:StudyForm ;
	isoC:label "Vital Signs"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/VITAL_SIGNS/V1#F> ;
.
<http://www.assero.co.uk/STBC#2c1e6576-58e4-4ce1-9c9a-9d55bc3ba508>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#14d3b4be-050d-47f7-af09-c026d6615551>
	rdf:type pr:StudyForm ;
	isoC:label "Randomization"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/RANDOM_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#b273f957-328b-4472-aeec-f3709563ad02>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#096864ae-2014-43a3-a8db-0656a4c859f4>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STBC#103713bb-1e29-4373-94a8-7c2a41fa1683>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#1c27b346-6104-4c5c-9f4f-4059672d97ad>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#e7e45411-132c-48e4-9b3b-16016f956402>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#c1ec56cf-769b-44a6-8327-d6d1c75c64dd>
	rdf:type pr:StudyForm ;
	isoC:label "Vital Signs"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/VITAL_SIGNS/V1#F> ;
.
<http://www.assero.co.uk/STBC#4396f2a9-f569-4890-9094-c6d6658870b7>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#af716b8b-fe7a-4a4d-8bf2-b3874d22ff06>
	rdf:type pr:StudyForm ;
	isoC:label "Routine Laboratory"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/LB_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#55f565be-c6a4-4f0f-abbb-de8e0f90dc86>
	rdf:type pr:StudyForm ;
	isoC:label "Cross-Over | Swap"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/X_OVER_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#29479fdb-cb07-4cb3-9a37-8c1d30026a65>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#44d393a2-6431-4704-8417-7dca96f63cd8>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STBC#fe6a9808-65d2-4291-b50c-1cd9eba877c6>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#9f48290d-086b-408a-a558-4f72e0749718>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#703e022e-e531-4033-8f7b-06edf484e919>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#158dcbdf-6cdd-492c-967e-6f8464436df0>
	rdf:type pr:StudyForm ;
	isoC:label "Vital Signs"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/VITAL_SIGNS/V1#F> ;
.
<http://www.assero.co.uk/STBC#0e66b3b1-6e38-443a-a255-7507cc26eb12>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#75478e4b-656b-471a-be40-cd5835363105>
	rdf:type pr:StudyForm ;
	isoC:label "Routine Laboratory"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/LB_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#8b18424f-57b8-4832-a041-1e60871087e3>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#e4ba66a6-2480-4e13-92f1-91961b0d4e09>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#b57ca734-7709-4b2e-9fe5-f33429716d5b>
	rdf:type pr:StudyForm ;
	isoC:label "Vital Signs"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/VITAL_SIGNS/V1#F> ;
.
<http://www.assero.co.uk/STBC#7b93c26e-3af5-4897-9d7d-04fde3ec8a05>
	rdf:type pr:StudyBiomedicalConcept ;
	isoC:label "Haemoglobin A1C"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HBA1C/V1#BCI> ;
.
<http://www.assero.co.uk/STFRM#aaa446c8-5187-4f3d-b2ba-26cc5f302b77>
	rdf:type pr:StudyForm ;
	isoC:label "Adverse Events"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/AE_DEMO/V1#F> ;
.
<http://www.assero.co.uk/STFRM#5126e0a1-b2e0-493c-a1d2-07e9525bbe7e>
	rdf:type pr:StudyForm ;
	isoC:label "Hypoglycaemic Event"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/HYPO_FORM/V1#F> ;
.
<http://www.assero.co.uk/STFRM#3a5d56a5-e476-44d9-80a9-0d717c00a57c>
	rdf:type pr:StudyForm ;
	isoC:label "Termination Record"^^xsd:string ;
	pr:isDerivedFrom <http://www.s-cubed.dk/TERMINATION_DEMO/V1#F> ;
.